IGFBP2 and pancreatic adenocarcinoma: Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 2 binding protein (IGFBP2) are associated with an increased risk of cancer development, including pancreatic adenocarcinoma (PDAC).